Concepedia

Violette Paragas

VP

22

Publications

2.4K

Citations

18

H-Index

1990

Active since

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

Stanford University

Genesis Foundation

Massachusetts General Hospital

Harvard University

Violette Paragas is an author at Merrimack Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1990–2023

22

Publications

22

Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis

Birgit Schoeberl, Emily A. Pace, Jonathan B. Fitzgerald et al. · Science Signaling · 2009 · 367 citations

GRAIL

Niroshana Anandasabapathy, Gregory S. Ford, Debra D. Bloom et al. · Immunity · 2003 · 284 citations · Full text

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

Charlotte F. McDonagh, Alexandra Huhalov, Brian D. Harms et al. · Molecular Cancer Therapeutics · 2012 · 274 citations · Full text

, , +18

Design and testing of a humanized porcine donor for xenotransplantation

R. Anand, Jacob V. Layer, Dávid Héja et al. · Nature · 2023 · 235 citations · Full text

The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.

Jayne S. Danska, Alexandra M. Livingstone, Violette Paragas et al. · The Journal of Experimental Medicine · 1990 · 183 citations · Full text

, , +19

Rows per page

1–5 of 22